5th International Conference on
Genetics, Gene Therapy & Regenerative Medicine (GENEX 2026)
October 19-21, 2026 | Singapore
October 19-21, 2026 | Singapore
Erat ipsum justo amet duo et elitr dolor, est duo duo eos lorem sed diam stet diam sed stet.
Erat ipsum justo amet duo et elitr dolor, est duo duo eos lorem sed diam stet diam sed stet.
Erat ipsum justo amet duo et elitr dolor, est duo duo eos lorem sed diam stet diam sed stet.
Welcome to GeneX Forum 2026, an international B2B forum bringing together leading researchers, scientists, clinicians, biotechnology innovators, pharmaceutical professionals, healthcare experts, industry leaders, and other key stakeholders to explore the future of genetics, gene therapy, regenerative medicine, and advanced therapeutics.
As rapid advances in genomics, gene therapy, genome editing, CRISPR technologies, cell therapy, stem cell research, regenerative medicine, precision medicine, and artificial intelligence continue to transform healthcare, GeneX Forum 2026 provides a dynamic platform for scientific exchange, knowledge sharing, strategic networking, and meaningful collaboration across the global life sciences ecosystem.
The forum will explore the latest developments in human gene therapy, genome editing and gene engineering, cell therapy and immune engineering, regenerative medicine and stem cell biology, tissue engineering and advanced biomaterials, precision medicine and rare diseases, AI-driven innovation in advanced therapies, regulatory science, clinical development, manufacturing, translation, and commercialization.
The scientific program will feature keynote presentations, plenary sessions, expert-led discussions, industry insights, scientific presentations, technology showcases, poster sessions, and networking opportunities, creating an environment for participants to discover emerging research, discuss innovative technologies, and exchange perspectives on the future of advanced medicine.
GeneX Forum 2026 is designed to connect the scientific and business communities and encourage collaboration between academia, biotechnology, pharmaceutical companies, healthcare organizations, technology providers, investors, and industry professionals. The forum aims to support the translation of promising discoveries and innovative technologies into real-world therapeutic applications while highlighting the opportunities and challenges shaping the future of precision healthcare.
Whether you are a researcher, clinician, academic, biotechnology professional, pharmaceutical executive, industry leader, investor, policymaker, or technology innovator, GeneX Forum 2026 offers an opportunity to connect with an international community, exchange knowledge, explore emerging technologies, and build valuable professional relationships.
Join us in Singapore from 19–21 October 2026 and be part of the global conversation shaping the future of genetics, gene therapy, regenerative medicine, cell and gene therapies, genome editing, precision medicine, and AI-driven healthcare.
GeneX Forum 2026 — Connecting Science, Innovation, and the Future of Advanced Therapies.
The convergence of genetics, genomics, gene therapy, regenerative medicine, and artificial intelligence is transforming modern healthcare and opening new possibilities for the prevention, diagnosis, and treatment of complex diseases. From genome sequencing and CRISPR-based gene editing to cell and gene therapies, stem cell research, tissue engineering, precision medicine, and AI-powered healthcare, scientific innovation is accelerating the development of more targeted and personalized therapeutic approaches.
GeneX Forum 2026 brings together an international community of scientists, clinicians, researchers, biotechnology innovators, pharmaceutical professionals, healthcare leaders, and industry experts to discuss the latest breakthroughs and emerging trends in genetics, gene therapy, regenerative medicine, and advanced therapeutic technologies.
The forum will provide a platform to explore cutting-edge research and discuss the journey from scientific discovery to clinical translation. Key discussions will focus on genome editing, gene engineering, cell therapy, immune engineering, regenerative medicine, stem cell biology, precision medicine, rare diseases, artificial intelligence, advanced biomanufacturing, regulatory science, clinical development, and commercialization.
Through keynote lectures, plenary sessions, scientific presentations, expert discussions, poster sessions, technology showcases, and networking opportunities, GeneX Forum 2026 will encourage knowledge exchange and foster connections across academia, healthcare, biotechnology, pharmaceuticals, and industry.
Join us in Singapore on 19–21 October 2026 to connect with global experts, discover emerging innovations, exchange ideas, and explore new opportunities for collaboration.
GeneX Forum 2026 — Where Science Meets Innovation, and Ideas Shape the Future of Healthcare.
Join leading researchers, clinicians, industry experts, investors, and innovators from around the world to shape the future of gene therapy and regenerative medicine.
GENEX 2026 will showcase cutting-edge research, breakthrough technologies, and emerging trends shaping the future of gene therapy, regenerative medicine, and precision healthcare.
GENEX 2026 is designed as a business-driven scientific conference, bringing together academia, biotechnology companies, pharmaceutical leaders, investors, clinicians, and innovators through exclusive networking and knowledge-sharing opportunities.
Hear from globally recognized pioneers sharing breakthrough discoveries and future directions.
Engage with CEOs, researchers, regulators, and healthcare leaders on emerging opportunities.
Discover innovative products, services, and technologies from leading organizations.
Explore disruptive ideas transforming gene therapy and regenerative medicine.
Emerging companies present innovative solutions to investors and industry leaders.
Experience the latest platforms, instruments, AI tools, and therapeutic technologies.
Schedule private meetings with potential collaborators, clients, and strategic partners.
Connect with investors, venture capital firms, and organizations seeking collaborations.
Showcase innovative research and interact with international scientific experts.
Highlight outstanding early-career researchers through dedicated presentations and awards.
CEOs, Directors, Founders, and Senior Leadership from biotech, pharma, and healthcare organizations
Leading researchers, principal investigators, laboratory scientists, and academic scholars
Physicians, geneticists, clinical trial specialists, and healthcare practitioners involved in advanced therapeutics
Professionals from R&D, manufacturing, regulatory affairs, quality control, and commercialization teams
Representatives from government agencies, health authorities, and policy advisory bodies
Deans, department heads, senior faculty members, and research administrators
Founders and innovators developing next-generation gene and cell therapy solutions
Members of NGOs, international health bodies, and advocacy groups focused on genetic and rare diseases
Graduate students, postdoctoral researchers, and early-career professionals entering the field
Financial leaders interested in funding emerging Genetics, Gene Therapy & Regenetive Medicine technologies
Science journalists, medical writers, and communication specialists covering biotech innovation
Experts in AI, bioinformatics, computational biology, and advanced therapeutic technologies
Developers of tools supporting gene delivery, cell processing, and laboratory research
Scientists and teams working on advanced biologics, RNA platforms, and new therapeutic modalities
Position your organization at the forefront of innovation by connecting with researchers, healthcare leaders, biotechnology companies, pharmaceutical executives, investors, and decision-makers from around the world.
Tempor erat elitr rebum at clita. Diam dolor diam ipsum sit. Aliqu diam amet diam et eos. Clita erat ipsum et lorem et sit, sed stet lorem sit clita duo justo magna dolore erat amet
Design Approach
Innovative Solutions
Project Management
Read More
"It was a pleasure ! Happy to continue contributing in future meetings."
" The speakers were of high quality, bringing a strong mix of industry and academic perspectives across preclinical, clinical, and CMC topics. The networking sessions were excellent, making the event well-organized and valuable overall. I look forward to future editions and would be happy to participate again."
"I enjoyed the conference very much and thank you for your hard work in organizing this great event. Looking forward to the future edition of the conference."
"Hi ,The conference was great - you had some excellent speakers that provided penetrating analysis - with high quality scientific and data and industry analysis displayed and discussed by articulate speakers."
"I was honored to be there, and I really had a great time, and I met a lot of professionals. The conference was very well organized."
"Thanks , the conference was nice, I got a lot out of it "
"The talks that I was able to attend were quite enlightening .. And exposure to the various companies/ attendees may be quite useful for networking and furthering our experiments."
"Thank you very much for your kind message and for the opportunity to participate in the Gene Therapy Forum 2026. It was a pleasure attending the event in Boston. I truly appreciated the high-quality scientific discussions, excellent organization, and the valuable interactions throughout the meeting.
Thank you again for hosting such a meaningful conference. I look forward to joining future Gene Therapy Forum events and meeting you in person."
"Thank you for the opportunity. The event was well organized and informative."
"I liked the smaller set-up for the conference—keeping it under 100 attendees is great for fostering discussion and allowing time to connect with speakers after their talks. The venue was good, and the food and catering were well organized."
“It was a great opportunity to present and attend the Gene Therapy Forum 2026. I was impressed by the strong panel of speakers from both industry and academia, covering current advances, challenges, and opportunities in Genetics, Gene Therapy & Regenetive Medicine. The discussions were insightful and well-structured, offering valuable takeaways and paving the way for broader global collaboration in future meetings.”
Tempor erat elitr rebum at clita. Diam dolor diam ipsum sit. Aliqu diam amet diam et eos. Clita erat ipsum et lorem et sit, sed stet lorem sit clita duo justo magna dolore erat amet
Call Us Now
Mail Us Now
Clita clita tempor justo dolor ipsum amet kasd amet duo justo duo duo labore sed sed. Magna ut diam sit et amet stet eos sed clita erat magna elitr erat sit sit erat at rebum justo sea clita.
Clita clita tempor justo dolor ipsum amet kasd amet duo justo duo duo labore sed sed. Magna ut diam sit et amet stet eos sed clita erat magna elitr erat sit sit erat at rebum justo sea clita.
Clita clita tempor justo dolor ipsum amet kasd amet duo justo duo duo labore sed sed. Magna ut diam sit et amet stet eos sed clita erat magna elitr erat sit sit erat at rebum justo sea clita.
